Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aimed to evaluate the risk of development of hepatocellular carcinoma (HCC) according to underlying liver status and virological response (VR) to entecavir (ETV) in chronic hepatitis B patients with cirrhosis. Procollagen III N-terminal peptide (PIIINP) concentration during ETV treatment and its association with HCC development were also evaluated.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Gastroenterol.

Title: The American journal of gastroenterology

ISSN (Electronic): 1572-0241

ISSN (Print): 0002-9270

Publication date (Electronic): Aug 2014

Volume: 109

Issue: 8

Affiliations

[1 ] Department of Gastroenterology, Ajou University School of Medicine, Suwon, South Korea.

Article

Publisher Item ID: ajg2014145

DOI: 10.1038/ajg.2014.145

PubMed ID: 24890440

SO-VID: c9c93e9c-a726-4f46-95ae-dc1a5e6eaf83

History

Data availability:

Comments

Comment on this article

scite_

Cited by 25

See all cited by